Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood|February 3, 2016
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivoCaroline Pabst, Anne Bergeron, Vincent-Philippe Lavallée, et al.
Blood Advances|September 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AMLJulia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
European Journal of Haematology|June 3, 2025
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I StudyMichael Kruszewski, Claudia Schmoor, Tobias Berg, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Nature Communications|March 2, 2021
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomicsLars Velten, Benjamin A Story, Pablo Hernández-Malmierca, et al.
Leukemia|June 21, 2020
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyMaxi Wass, Stefanie Göllner, Birgit Besenbeck, et al.
Blood|May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AMLSwati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
Cancer Discovery|March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/VenetoclaxAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Cancer Discovery|October 19, 2022
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid LeukemiaFengbiao Zhou, Nesrine Aroua, Yi Liu, et al.
Pageof 5